---
title: Verana Health + Ocular Therapeutix White Paper
image: https://info.veranahealth.com/hubfs/Verana-Ocular-White-Paper-Post-wide.png
---

[![Verana Health](https://info.veranahealth.com/hs-fs/hubfs/VeranaHealth_Logo.png?width=1464&height=210&name=VeranaHealth_Logo.png "Verana Health")](https://www.veranahealth.com/)

# The Power of Real-World Data to Detect Adverse Events and Expedite FDA Postmarking Safety Commitments

![Verana Ocular Email Header (1)-1](https://info.veranahealth.com/hubfs/Verana%20Ocular%20Email%20Header%20(1)-1.png "Verana Ocular Email Header (1)-1")

## Access Your Copy of the White Paper

To overcome the limitations inherent in traditional clinical trials, researchers increasingly are turning to real-world data (RWD) to provide a picture of a drug’s efficacy and safety. One example is our work with Ocular Therapeutix to satisfy FDA postmarketing safety requirements.

![ocular_whitepaper](https://info.veranahealth.com/hs-fs/hubfs/ocular_whitepaper.png?width=250&height=325&name=ocular_whitepaper.png "ocular_whitepaper")

This white paper includes:

1. Why point-of-care EHR data is a game changer
2. Details on the Ocular Therapeutix ReSure Sealant Study
3. FDA and the use of real-world data

Complete the form to access your copy.

*Please do not send any Protected Health Information (PHI) when submitting this form. This form is not encrypted and it is not a suitable method for transmitting PHI. Any PHI sent to Verana Health via this form is deemed to be authorized by the subject of the PHI.*

![Dots Divider](https://info.veranahealth.com/hubfs/Dots/Dots%20Divider.png "Dots Divider")

© 2026 Verana Health All rights reserved.

[Privacy Policy](https://www.veranahealth.com/privacy-policy)